Representative before the EPO

Company dna cooley uk llp
no operation time available
2 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna venner shipley llp
operating since 1947
Headquarter in London and 5 offices
active in Legal Services and IP Consulting

We have observed 21 EP applications Tanya Heare has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12777938

CONTINUOUS EXTENSION AND DEBLOCKING IN REACTIONS FOR NUCLEIC ACID SYNTHESIS AND SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
Illumina, Inc.
Agent:
Multiple attorneys, Cooley (UK) LLP
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP12798817

SLEEVE FOR A SMOKING ARTICLE

IPC classification:
A24F 13/22, A24F 13/02
Applicant:
British American Tobacco (Investments) Ltd
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP12750728

NANOPARTICLES AND USES THEREOF

IPC classification:
A61K 49/18, A61K 49/00, A61K 47/48, A61P 35/00, A61P 9/10, A61P 9/04
Applicant:
Biocant - Associação De Transferência De Tecnologia
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP11853913

DELIVERY OF TREATMENTS TRANSDERMALLY FOR FUNGAL INFECTIONS AND OTHER INDICATIONS

IPC classification:
A61K 31/198, A61K 31/137, A61K 47/26, A61K 47/16, A61K 47/10, A61K 47/36, A61K 9/107, A61K 31/74
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11854321

SYSTEMS AND METHODS FOR TREATMENT OF ALLERGIES AND OTHER INDICATIONS

IPC classification:
A61K 9/107, A61K 31/74, A61K 47/36, A61K 47/26, A61K 47/18, A61K 47/10
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11852275

TREATMENT OF ERECTILE DYSFUNCTION AND OTHER INDICATIONS

IPC classification:
A61K 47/16, A61K 47/36, A61K 47/26, A61K 47/10, A61K 9/70, A61K 9/107, A61K 31/48, A61K 31/54, A61K 31/522, A61K 31/4465, A61K 31/422, A61K 31/4196, A61K 31/404, A61K 31/4045, A61K 31/403, A61K 38/00
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP13717772

ANTIMICROBIAL COMPLEXES

IPC classification:
A01P 1/00, A01N 33/12, A01N 25/34, A01N 25/30, A01N 25/28
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP13727321

METHODS AND SYSTEMS FOR DETERMINING HAPLOTYPES AND PHASING OF HAPLOTYPES

IPC classification:
C12Q 1/68
Applicant:
Illumina Cambridge Ltd
Agent:
Multiple attorneys, Cooley (UK) LLP
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
The patent has been granted
EP14398006

Neonatal vaccine

IPC classification:
C07K 14/495
Applicant:
University of Porto (Universidade do Porto)
Agent:
Tanya Heare, Venner Shipley LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15179339

TRANSPOSON END COMPOSITIONS AND METHODS FOR MODIFYING NUCLEIC ACIDS

IPC classification:
H01M 10/42, H01M 6/50, H01M 6/14
Agent:
Multiple attorneys, Cooley (UK) LLP
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
PATENT GRANTED
EP14721633

TRANSDERMAL DELIVERY OF SILDENAFIL AND OTHER PHOSPHODIESTERASE TYPE 5 INHIBITORS

IPC classification:
A61K 31/519, A61K 47/18, A61K 47/12, A61K 47/10, A61K 47/02, A61K 9/107, A61K 9/06
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP14724202

TRANSDERMAL FORMULATIONS OF FLUTICASONE

IPC classification:
A61K 31/00, A61K 9/70, A61K 9/06, A61K 47/02, A61K 9/00
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP14721704

MATERIALS, SYSTEMS, DEVICES, AND METHODS FOR ENDOLUMINAL ELECTROPOLYMERIC PAVING AND SEALING

IPC classification:
A61F 2/945, A61L 31/16, A61L 31/14
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP14762727

METHODS OF DELIVERING NANOSHELLS INTO SEBACEOUS GLANDS

IPC classification:
B82Y 5/00, A61P 17/10, A61M 37/00
Applicant:
University of California
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP15201165

APPARATUS AND METHOD FOR SEPARATING AND CONCENTRATING FLUIDS CONTAINING MULTIPLE COMPONENTS

IPC classification:
B01D 17/038, G01N 33/49, B01L 3/00, B01L 3/14
Applicant:
Biomet Manufacturing LLC
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP15197029

IMPROVED METHODS OF NUCLEIC ACID SEQUENCING

IPC classification:
C12Q 1/68
Applicant:
Illumina Cambridge Ltd
Agent:
Tanya Heare, Cooley (UK) LLP
Agent:
Tanya Heare, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP16155567

OLIGONUCLEOTIDE REPLACEMENT FOR DI-TAGGED AND DIRECTIONAL LIBRARIES

IPC classification:
C12N 15/11, C12Q 1/68, C12N 15/10
Applicant:
Illumina, Inc.
Agent:
Tanya Heare, Cooley (UK) LLP
Agent:
Tanya Heare, Venner Shipley LLP
Status:
EXAMINATION REQUESTED
EP11853771

METHODS AND SYSTEMS FOR TREATMENT OF MIGRAINES AND OTHER INDICATIONS

IPC classification:
A61K 47/36, A61K 47/26, A61K 47/10, A61K 9/70, A61K 9/107, A61K 31/48, A61K 31/54, A61K 31/522, A61K 31/4465, A61K 31/422, A61K 31/4196, A61K 31/404, A61K 31/4045, A61K 31/403, A61K 38/00
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP11854161

COX-2 INHIBITORS AND RELATED COMPOUNDS, AND SYSTEMS AND METHODS FOR DELIVERY THEREOF

IPC classification:
A61K 31/365, A61K 31/635, A61K 31/63, A61K 47/36, A61K 47/26, A61K 47/10, A61K 9/70, A61K 9/107, A61K 31/48, A61K 31/54, A61K 31/522, A61K 31/4465, A61K 31/422, A61K 31/4196, A61K 31/404, A61K 31/4045, A61K 31/403, A61K 38/00
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
EXAMINATION IN PROGRESS
EP16158303

TOPICAL COMPOSITION

IPC classification:
A61K 9/06, A61K 31/19
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED
EP14789714

FIXED CHAMBER SEPARATOR WITH ADJUSTMENT WITHDRAWAL MEMBER

IPC classification:
B01L 3/14
Applicant:
Biomet Biologics LLC
Agent:
Multiple attorneys, Venner Shipley LLP
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature